| August 3 |
Repros Therapeutics Inc. Suspends Dosing of Proellex and Provides Update on Financial Status |
| August 3 |
U.S. District Court Issues in Favor of Daiichi Sankyo Regarding Patent Litigation for Benicar, Benicar HCT and Azor |
| August 3 |
Nycomed to Acquire Local Portfolio from Sanofi-Aventis and Zentiva |
| August 3 |
European Medicines Agency and U.S. Food and Drug Administration (FDA) launch Good Clinical Practice Initiative |
| August 4 |
MedWatch - Botox and Botox Cosmetic and Myobloc:changes to drug names to reinforce individual potencies and prevent medication errors, recommendations for healthcare professionals to consider, information for patients, family members |
| August 4 |
Antidepressant Use Increasing In the United States |
| August 4 |
Lilly, Chao Center, PDA partner with Russian officials to improve quality of global drug manufacturing, distribution |
| August 4 |
Amgen and Wyeth Statement on FDA Announcement About Tumor Necrosis Factor (TNF) Blockers |
| August 4 |
MedWatch - Tumor Necrosis Factor (TNF) Blockers: Boxed Warning describing increased risk of lymphoma in children, adolescents treated with TNF blockers |
| August 5 |
Anesiva, Inc. and Arcion Therapeutics Announce Merger Agreement |
| August 5 |
Dynavax Announces Path for HEPLISAV Hepatitis B Vaccine Development |
| August 5 |
Merck and Schering-Plough Resolve Previously Disclosed Civil Class Action Lawsuits Related to Vytorin (ezetimibe/simvastatin) and Zetia (ezetimibe) |
| August 5 |
Shire plc: Core Portfolio of Products Delivers 20% Sales Growth |
| August 5 |
FDA: Cancer Warnings Required for TNF Blockers |
| August 5 |
Withdrawal Of The Marketing Authorisation In The European Union |
| August 5 |
The Foundation for National Institutes of Health Announces Unprecedented Product Donation by sanofi-aventis in the U.S. |
| August 5 |
Teva Announces Appeals Court Ruling Affirming Invalidation of Yasmin Patent |
| August 6 |
King Pharmaceuticals Reports Second Quarter 2009 Financial Results |
| August 6 |
Med Ad News? PharmaMed Marketing & Media Conference Announces Updates to the Three Innovative Sales-Force-Effectiveness, Digital Marketing & Patient Centered Communication Tracks |
| August 6 |
NicOx reacquires rights to PF-03187207 for glaucoma from Pfizer |
| August 6 |
Pharmaceutical & Medical Packaging News Launches New Website Featuring Breaking News & More Industry Resources For Healthcare Packaging Professionals |
| August 6 |
U.S. Payers Intend to Limit Preferred Coverage to Only One Immune Biologic |
| August 6 |
Baxter Completes Production of First Commercial Batches of A/H1N1 Pandemic Vaccine |
| August 6 |
Elan Files Declaratory Suit Against Biogen Idec; Company Has Not Breached Tysabri Collaboration Agreement |
| August 6 |
Vernalis and GlaxoSmithKline Enter Into a Collaboration, Option and License Agreement Over a Novel Vernalis Oncology Programme |
| August 7 |
Active Biotech (SE) - New information regarding RhuDex |
| August 7 |
Antisoma plc (UK) - Antisoma Announces Discontinuation of Development of AS1402 |
| August 7 |
FDA Commissioner Sets Out Vision on Enforcement to Support Public Health |
| August 7 |
FDA Issues Pharmaceutical Industry Guidance on Preventing Melamine Contamination |
| August 7 |
Merck Shareholders Approve Merger With Schering-Plough |
| August 7 |
Nabi Biopharmaceuticals Announces Sale of PentaStaph to GlaxoSmithKline PLC |
| August 7 |
Alzheimer's Drug Discovery Foundation-Funded PharmatrophiX Reaches Major Milestone |
| August 10 |
Nycomed and Forest Laboratories to Collaborate on Daxas (roflumilast) for COPD |
| August 11 |
Astellas Seeks Rigorous Testing and Safety-Related Labeling for Anti-Rejection Medications |
| August 11 |
Novartis International AG (CH) - Sandoz Launches First Generic Version of Prograf Capsules |
| August 11 |
Statement on Fosamax (alendronate sodium) Product Liability Trial in U.S. District Court |
| August 12 |
Schering-Plough Announces Resolution of Litigations on U.S. Marketing of Generic Forms of Solid Oral Dosage Forms of Clarinex |
| August 12 |
Dwayne Johnson, Novo Nordisk and the Entertainment Industry Foundation Educate Families about Healthy Living and Diabetes |
| August 12 |
Bristol-Myers Squibb Announces Expiration of Hart-Scott-Rodino Review Period for Acquisition of Medarex, Inc. |
| August 13 |
FDA Issues Final Rules to Help Patients Gain Access to Investigational Drugs |
| August 13 |
Stada Chief Financial Officer departs |
| August 13 |
STADA with development as planned in H1/2009: Sales: EUR 755.2 million, net income EUR 48.3 million ? outlook confirmed |
| August 13 |
Update on Astellas' Complaint Challenging the FDA's Decision for Citizen Petition in the US |
| August 13 |
Mylan Pharmaceuticals Receives Final FDA Report and Reaffirms Its 48-Year Exemplary Record of Quality |
| August 14 |
Supply Shortage Of Cerezyme ? Updated Treatment Recommendations Required |
| August 14 |
NEHI Research Shows Patient Medication Nonadherence Costs Health Care System $290 Billion Annually |
| August 14 |
FDA MedWatch - CellCept (mycophenolate mofetil) - cases of Pure Red Cell Aplasia reported in patients treated with CellCept |
| August 17 |
Gilead Sciences Receives Subpoena from U.S. Department of Health & Human Services Regarding Ranexa |
| August 18 |
U.S. District Court Rules Against Lilly Regarding Gemzar Patent |
| August 18 |
Geron's IND for Spinal Cord Injury Placed on Hold |
| August 18 |
Transcept Announces Plans to Reduce Expenses by Decreasing Staff Following Recent Completion of Purdue U.S. License and Collaboration Agreement |
| August 18 |
Par Pharmaceutical Wins on Invalidity in Ultram ER Litigation |
| August 19 |
Basilea Pharmaceutica Ltd. (CH) - FDA Issues Warning Letter to Johnson & Johnson Related to Ceftobiprole |
| August 19 |
FDA Sends J&J Warning Letter Over Trial Conditions |
| August 19 |
PhRMA Statement on Commitment to Health Care Reform |
| August 19 |
Mylan Files Lawsuit Against Pittsburgh Post-Gazette |
| August 19 |
Merck Wins Singulair Patent Infringement Lawsuit |
| August 19 |
Pfizer And Private Access Announce Plans To Develop Online Community To Accelerate Clinical Research |
| August 19 |
US Physicians Define Healthcare Reform Platform on Sermo |
| August 20 |
ZymoGenetics Submits Citizen Petition to FDA Requesting Removal of Bovine Thrombin from Market in the Interest of Patient Safety |
| August 20 |
Secure eHealth License Holder Private Access, Inc. Announces Commercial Beta Release of Privacy-Enhanced Search Technology, Including Collaboration with Pfizer, Inc. |
| August 20 |
Bristol-Myers Squibb Announces Preliminary Court Approval of Derivative Settlement |
| August 21 |
FDA Proposes Mandatory Electronic Safety Reporting |
| August 21 |
Bristol-Myers Squibb Extends Tender Offer for Medarex, Inc. |
| August 21 |
Merck is Pleased the FDA and CDC Re-Affirm the Safety Profile of Gardasil [Human Papillomavirus Quadrivalent (Types 6, 11, 16 and 18) Vaccine, Recombinant] |
| August 21 |
MediciNova and Avigen Enter Into Definitive Agreement for Business Combination |
| August 21 |
Off-label use: Oft not evidence based |
| August 21 |
Astellas: Reorganization of Drug Discovery Research Functions |
| August 21 |
Palio Announces Partnership with Zemoga |
| August 21 |
Diabetes drug linked to increased risk of heart failure |
| August 24 |
FDA Issues Warning Letters to Several, Including Allergan, Galderma Laboratories and Johnson & Johnson Pharmaceutical Research & Development |
| August 24 |
UCB Further Strengthens its Second Largest Market, Germany |
| August 24 |
Shire Builds Competitive Position of its HGT Business through Research Collaboration with Santaris Pharma A/S on LNA Drug Platform |
| August 24 |
ARIAD And Its Co-Plaintiffs Announce That the Court of Appeals Granted Their Petition for Rehearing En Banc In the Lilly NF-kB Patent Lawsuit |
| August 24 |
Warner Chilcott Acquires P&G's Global Pharmaceuticals Business |
| August 25 |
FDA Issues Early Communication about Ongoing Safety Review of Weight Loss Drug Orlistat |
| August 25 |
Ligand to Acquire Neurogen for Stock and Contingent Value Rights |
| August 25 |
GSK Advisory: Warehouse Theft |
| August 25 |
MedWatch - Orlistat (marketed as Alli and Xenical): FDA reviewing reports of serious liver injury, including liver failure |
| August 25 |
Cambrex Receives FDA Warning Letter |
| August 25 |
Study: 3 out of 4 U.S. Nurses Recommend Health Websites to Patients |
| August 25 |
Wyeth Continues Research Project Originally Initiated In Collaboration With Karo Bio |
| August 25 |
Lawsuit Claims Celgene Corporation Misappropriated the Idea Behind its Multiple Myeloma Treatments |
| August 26 |
GlaxoSmithKline Statement Confirming alli Safety |
| August 27 |
FDA Warns About Stolen Insulin |
| August 27 |
FDA Sends Johnson & Johnson and Pedinol Pharmacal Warning Letters |
| August 27 |
Geron Comments on FDA Hold on Spinal Cord Injury Trial |
| August 27 |
Abbott to Collaborate With Pfizer Inc on Companion Diagnostic Test to Select Patient Candidates for Novel Investigational Non-Small Cell Lung Cancer Therapy |
| August 27 |
WPP Interim Results 2009 |
| August 27 |
Filing: Ortho-McNeil Drops Injectable Risperdone Development. |
| August 27 |
Pfizer and Astellas Announce Co-promotion Agreement for Caduet Combination Tablets |
| August 27 |
Taisho Pharmaceutical: Discontinuation of Development of NT-702 for a Part of Indications |
| August 27 |
Bristol-Myers Squibb Completes Initial Tender Offer for Medarex, Inc. with 87.7% of Shares Tendered; Announces Subsequent Offering Period |
| August 27 |
Pharmalive.Com Launches New Bioscience Investment Report |
| August 28 |
MedWatch - Intelence (etravirine):Reports of severe, potentially life-threatening and fatal skin reactions |
| August 31 |
Jim New Steps Down as CEO of LifeCycle Pharma Today |
| August 31 |
Merck CEO Announces Structure and Global Leadership Team for New Merck |
